A possible role of VEGF in osteolytic bone metastasis of hepatocellular Carcinoma

Journal of Experimental and Clinical Cancer Research

Volumn 21, Issue 3, 2002, Pages 309-313

  Iguchi, Harou ^a   Yokota, M ^a   Fukutomi, M ^a   Uchimura, K ^a   Yonemasu, H ^a   Hachitanda, Y ^a   Nakao, Y ^a   Tanaka, Y ^a   Sumii, T ^a   Funakoshi, A ^a  

^a NATIONAL KYUSHU CANCER CENTER   (Japan)

Author keywords

Bone metastasis; Bone resorption; Hepatocellular carcinoma; VEGF

Indexed keywords

ANGIOGENIC FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BONE METASTASIS; CANCER INVASION; CANCER SURVIVAL; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL;

BONE NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; ENDOTHELIAL GROWTH FACTORS; HEPATITIS, CHRONIC; HUMANS; IMMUNOENZYME TECHNIQUES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LYMPHOKINES; OSTEOLYSIS; PEPTIDE FRAGMENTS; PROCOLLAGEN; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036737095     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Fukutomi M., Yokota M., Chuman H., et al.: Increased incidence of bone metastases in hepatocellular carcinoma. Eur. J. Gastroentero. Hepatol. 2001 (in press). 13: 1083-1088, 2001.
2. Guise T.A., Munday G.R.: Cancer and bone. Endocr. Rev. 19: 18-54, 1998.
3. Klagsbrun M., D'Amore P.A.: Vascular endothelial growth factor and its receptor. Cytokine Growth Factor Rev. 7: 259-270, 1996.
4. Niida S., Kaku M., Amano H., et al.: Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. J. Exp. Med. 190: 293-298, 1999.
5. Nakagawa M., Kaneda T., Arakawa T., et al.: Vascular endothelial growth factor (VEGF) directory enhances osteoclastic bone resorption and survival of mature osteoclasts. FEBS Lett. 473: 161-164, 2000.
6. Yamane A., Seetharam L., Yamaguchi S., et al.: A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1). Oncogene 9: 2683-2690, 1994.
7. Yamaguchi R., Yano H., Iemura A., et al.: Expression of vascular endothelial growth factor in human hepatocellular carcinoma. Hepatology 28: 68-77, 1998.
8. George M.L., Eccles S.A., Tutton M.G., Abulafi A.M., Swift R.I.: Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: Clinical evidence of platelet scavenging? Clin. Cancer Res. 6: 3147-3152, 2000.
9. Iguchi H., Tanaka S., Ozawa Y., et al.: An experimental Model of bone metastasis by human lung cancer cells: The role of parathyroid hormone-relatedd protein in bone metastasis. Cancer Res. 56: 4040-4043, 1996.
10. Guise T.A., Yin J.J., Taylor S.D., et al.: Evidence for a causal role for parathyroid hormone-related protein in human breast cancer-mediated osteolysis. J. Clin. Invest. 98: 1544-1549, 1996.
11. Ferrara N.: Vascular endothelial growth factor. Eur. J. Cancer 32A: 2413-2422, 1996.
12. Berenson J.R., Rosen L.S., Howell A., et al.: Zoledronic Acid reduces skeletal-related events in patients with osteolytic metastases. Cancer 91: 1191-1200, 2001.